LATIN AMERICA NASAL SPRAY MARKET 2021-2028

 

 

TABLE OF CONTENTS

 

1.     LATIN AMERICA NASAL SPRAY MARKET - SUMMARY

2.     INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON NASAL SPRAY MARKET

2.2. KEY INSIGHTS

2.2.1.    ALLERGY TREATMENTS WITH NASAL SPRAYS

2.2.2.    UTILIZING NASAL SPRAY FOR DIABETES

2.2.3.    ENDOMETRIOSIS TREATMENT WITH NASAL SPRAYS

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1.    THREAT OF NEW ENTRANTS

2.3.2.    THREAT OF SUBSTITUTES

2.3.3.    BARGAINING POWER OF BUYERS

2.3.4.    BARGAINING POWER OF SUPPLIERS

2.3.5.    THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY MARKET STRATEGIES

2.6.1.    MERGERS & ACQUISITIONS

2.6.2.    CONTRACTS & AGREEMENTS

2.6.3.    DIVESTITURES

2.7. MARKET DRIVERS

2.7.1.    EMERGING INTRANASAL VACCINES FOR COVID-19

2.7.2.    INCREASING ACCEPTANCE OF SELF-ADMINISTRATION OF MEDICATION

2.7.3.    GROWING USE OF NASAL SPRAYS DUE TO SIMPLE ADMINISTRATION TECHNIQUES

2.8. MARKET CHALLENGES

2.8.1.    COMPLICATIONS DUE TO EXCESS USE OF NASAL SPRAYS

2.9. MARKET OPPORTUNITIES

2.9.1.    APPLICATION OF NASAL SPRAYS IN TREATING DEPRESSION

2.9.2.    USING INTRANASAL TREATMENTS FOR CENTRAL NERVOUS SYSTEM DISORDERS

2.9.3.    EMPLOYING NASAL SPRAY AS A VACCINE

3.     LATIN AMERICA NASAL SPRAY MARKET OUTLOOK - BY TYPE

3.1. DECONGESTION NASAL SPRAY

3.2. STEROID NASAL SPRAY

3.3. SALTWATER SOLUTION/SALINE NASAL SPRAY

4.     LATIN AMERICA NASAL SPRAY MARKET OUTLOOK - BY PRESCRIPTION

4.1. OVER-THE-COUNTER

4.2. PRESCRIBED

5.     LATIN AMERICA NASAL SPRAY MARKET OUTLOOK - BY THERAPEUTIC

5.1. ANTIHISTAMINE

5.2. NASAL STEROIDS

5.3. ANTICHOLINERGIC

5.4. MAST CELL INHIBITOR

6.     LATIN AMERICA NASAL SPRAY MARKET OUTLOOK - BY APPLICATION

6.1. NASAL CONGESTION

6.2. ALLERGIC AND NON-ALLERGIC RHINITIS

6.3. VACCINATION

6.4. CNS DISORDERS

6.5. OTHER APPLICATIONS

7.     LATIN AMERICA NASAL SPRAY MARKET OUTLOOK - BY END-USER

7.1. HOME CARE SETTING

7.2. ASC/CLINICS

7.3. PHARMACY

7.4. HOSPITAL

7.5. OTHER END-USERS

8.     LATIN AMERICA NASAL SPRAY MARKET – REGIONAL OUTLOOK

8.1. BRAZIL

8.2. MEXICO

8.3. REST OF LATIN AMERICA

9.     COMPETITIVE LANDSCAPE

9.1. AKORN

9.2. ALLERGAN

9.3. APOTEX INC

9.4. BHARAT BIOTECH

9.5. CATALENT INC

9.6. CIPLA LIMITED

9.7. GLAXOSMITHKLINE

9.8. JOHNSON AND JOHNSON

9.9. NOVARTIS INTERNATIONAL AG

9.10.               PFIZER INC

9.11.               PROCTOR AND GAMBLE CO

9.12.               SANOTIZE RESEARCH AND DEVELOPMENT

9.13.               SUN PHARMACEUTICALS INDUSTRIES LTD

9.14.               TEVA PHARMACEUTICAL INDUSTRIES LTD

9.15.               VIATRIS

10. RESEARCH METHODOLOGY & SCOPE

10.1.               RESEARCH SCOPE & DELIVERABLES

10.2.               SOURCES OF DATA

10.3.               RESEARCH METHODOLOGY

 

 

TABLE LIST

 

TABLE 1: LATIN AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 2: VENDOR SCORECARD

TABLE 3: LATIN AMERICA NASAL SPRAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 4: LATIN AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2021-2028 (IN $ MILLION)

TABLE 5: LATIN AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2021-2028 (IN $ MILLION)

TABLE 6: LATIN AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 7: LATIN AMERICA NASAL SPRAY MARKET, BY END-USER, 2021-2028 (IN $ MILLION)

TABLE 8: LATIN AMERICA NASAL SPRAY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

 

 

FIGURE LIST

 

FIGURE 1: MARKET ATTRACTIVENESS INDEX

FIGURE 2: LATIN AMERICA NASAL SPRAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 3: LATIN AMERICA NASAL SPRAY MARKET, BY DECONGESTION NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 4: LATIN AMERICA NASAL SPRAY MARKET, BY STEROID NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 5: LATIN AMERICA NASAL SPRAY MARKET, BY SALTWATER SOLUTION/SALINE NASAL SPRAY, 2021-2028 (IN $ MILLION)

FIGURE 6: LATIN AMERICA NASAL SPRAY MARKET, BY PRESCRIPTION, 2020 & 2028 (IN %)

FIGURE 7: LATIN AMERICA NASAL SPRAY MARKET, BY OVER-THE-COUNTER, 2021-2028 (IN $ MILLION)

FIGURE 8: LATIN AMERICA NASAL SPRAY MARKET, BY PRESCRIBED, 2021-2028 (IN $ MILLION)

FIGURE 9: LATIN AMERICA NASAL SPRAY MARKET, BY THERAPEUTIC, 2020 & 2028 (IN %)

FIGURE 10: LATIN AMERICA NASAL SPRAY MARKET, BY ANTIHISTAMINE, 2021-2028 (IN $ MILLION)

FIGURE 11: LATIN AMERICA NASAL SPRAY MARKET, BY NASAL STEROIDS, 2021-2028 (IN $ MILLION)

FIGURE 12: LATIN AMERICA NASAL SPRAY MARKET, BY ANTICHOLINERGIC, 2021-2028 (IN $ MILLION)

FIGURE 13: LATIN AMERICA NASAL SPRAY MARKET, BY MAST CELL INHIBITOR, 2021-2028 (IN $ MILLION)

FIGURE 14: LATIN AMERICA NASAL SPRAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 15: LATIN AMERICA NASAL SPRAY MARKET, BY NASAL CONGESTION, 2021-2028 (IN $ MILLION)

FIGURE 16: LATIN AMERICA NASAL SPRAY MARKET, BY ALLERGIC AND NON-ALLERGIC RHINITIS, 2021-2028 (IN $ MILLION)

FIGURE 17: LATIN AMERICA NASAL SPRAY MARKET, BY VACCINATION, 2021-2028 (IN $ MILLION)

FIGURE 18: LATIN AMERICA NASAL SPRAY MARKET, BY CNS DISORDERS, 2021-2028 (IN $ MILLION)

FIGURE 19: LATIN AMERICA NASAL SPRAY MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

FIGURE 20: LATIN AMERICA NASAL SPRAY MARKET, BY END-USER, 2020 & 2028 (IN %)

FIGURE 21: LATIN AMERICA NASAL SPRAY MARKET, BY HOME CARE SETTING, 2021-2028 (IN $ MILLION)

FIGURE 22: LATIN AMERICA NASAL SPRAY MARKET, BY ASC/CLINICS, 2021-2028 (IN $ MILLION)

FIGURE 23: LATIN AMERICA NASAL SPRAY MARKET, BY PHARMACY, 2021-2028 (IN $ MILLION)

FIGURE 24: LATIN AMERICA NASAL SPRAY MARKET, BY HOSPITAL, 2021-2028 (IN $ MILLION)

FIGURE 25: LATIN AMERICA NASAL SPRAY MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

FIGURE 26: LATIN AMERICA NASAL SPRAY MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)

FIGURE 27: BRAZIL NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28: MEXICO NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29: REST OF LATIN AMERICA NASAL SPRAY MARKET 2021-2028 (IN $ MILLION)

 

 

MARKET OUTLOOK

 

Triton’s research report on the nasal spray market in Latin America suggests that the market is expected to show growth at a compound annual growth rate of 7.46% during the evaluated period 2021-2028. Mexico, Brazil, and Rest of Latin America shape the market in this region.

In Argentina, respiratory diseases are the third cause of mortality. Besides, the country has a high prevalence of asthma. Additionally, a significant number of children suffer from allergic rhinitis. Furthermore, as per estimates, chronic respiratory diseases have led to a significant amount of death over the past years. Here, COPD affects around 2.3 million citizens of the country. Above all, lung diseases have witnessed substantial growth in the region. Hence, these factors are supplementing the adoption of nasal sprays, thereby contributing to the growth of the nasal spray market.

Likewise, chronic obstructive pulmonary disease is highly prevalent in Chile. Earlier, as per WHO, lung disease resulted in a high number of mortalities across the country. Moreover, pneumonia is another major cause of death in the country. As per estimates, lung disease and pneumonia led to a rise in mortalities by approximately 5.07% and 4.91%, respectively. Therefore, as stated above, these factors have surged the demand for nasal spray, which will drive the growth of the nasal spray market In Chile.

 

 

COMPETITIVE OUTLOOK

 

The popular companies in the nasal spray market are Sanotize Research and Development, Teva Pharmaceutical Industries Ltd, Allergan, Akorn, Apotex Inc, Pfizer Inc, and Bharat Biotech.

 

Get more insights into the Latin America Nasal Spray Market:

 

https://www.tritonmarketresearch.com/reports/latin-america-nasal-spray-market

 

SEGMENTATION

 

1.     AKORN

2.     ALLERGAN

3.     APOTEX INC

4.     BHARAT BIOTECH

5.     CATALENT INC

6.     CIPLA LIMITED

7.     GLAXOSMITHKLINE

8.     JOHNSON AND JOHNSON

9.     NOVARTIS INTERNATIONAL AG

10. PFIZER INC

11. PROCTOR AND GAMBLE CO

12. SANOTIZE RESEARCH AND DEVELOPMENT

13. SUN PHARMACEUTICALS INDUSTRIES LTD

14. TEVA PHARMACEUTICAL INDUSTRIES LTD

15. VIATRIS